BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20498310)

  • 1. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
    Yang SJ; Nast CC; Mishra NN; Yeaman MR; Fey PD; Bayer AS
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3079-85. PubMed ID: 20498310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
    PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
    Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
    Yang SJ; Xiong YQ; Boyle-Vavra S; Daum R; Jones T; Bayer AS
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3161-9. PubMed ID: 20547804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.
    Bertsche U; Weidenmaier C; Kuehner D; Yang SJ; Baur S; Wanner S; Francois P; Schrenzel J; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3922-8. PubMed ID: 21606222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.
    Yang SJ; Mishra NN; Rubio A; Bayer AS
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5658-64. PubMed ID: 24002096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons.
    Mishra NN; Bayer AS; Weidenmaier C; Grau T; Wanner S; Stefani S; Cafiso V; Bertuccio T; Yeaman MR; Nast CC; Yang SJ
    PLoS One; 2014; 9(9):e107426. PubMed ID: 25226591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.